N-Glycan profiling of dried blood spots.

Serum N-glycan profiles for use as clinical biomarkers of disease(s) is of increasing scientific interest. Promising profiles have already been identified in several diseases, including cancer, Alzheimer's, and diabetes. Venipuncture is routinely performed to collect the blood necessary for this type of analysis, but blood from a fingerstick placed on filter paper (known as dried blood spots (DBS)) is more advantageous. This sampling method is less invasive than "classical" blood drawing, can be performed conveniently at home, and avoids cumbersome shipping and storage procedures. Here, we present a procedure for N-glycan profiling of DBS samples consisting of reconstitution of DBS in N-glycan release buffer, protein denaturation, enzymatic N-glycan release and PGC Solid phase extraction (SPE) for purification. Samples are then analyzed using nanoHPLC-PGC-chip-TOF-MS to generate N-glycan profiles. Using this method, ~150 N-glycan structures can be monitored, originating from 44 N-glycan compositions that can be analyzed with good repeatability (the coefficient of variation (%CV) is ~20%). To assess the stability of the N-glycans during storage, DBS samples were stored at room temperature (RT) and -80 °C. No major differences in N-glycan composition could be observed. Moreover, upon comparison of the N-glycan profile of DBS with profiles obtained from serum, which is a classical matrix for N-glycan profiling, similar patterns were observed. The method facilitates large population studies for N-glycan profiling, and is especially advantageous for children and the elderly, who have limited blood supplies, as well as animal studies in small mammals.

[1]  Martin Pabst,et al.  Glycan analysis by modern instrumental methods , 2011, Proteomics.

[2]  Scott R. Kronewitter,et al.  Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. , 2010, Journal of proteome research.

[3]  Scott R. Kronewitter,et al.  The development of retrosynthetic glycan libraries to profile and classify the human serum N‐linked glycome , 2009, Proteomics.

[4]  R. Guthrie,et al.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. , 1963, Pediatrics.

[5]  David J. Harvey,et al.  HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. , 2008, Analytical biochemistry.

[6]  André M Deelder,et al.  Plasma protein N-glycan profiles are associated with calendar age, familial longevity and health. , 2011, Journal of proteome research.

[7]  J. Millership Microassay of drugs and modern measurement techniques , 2011, Paediatric anaesthesia.

[8]  P. Levy An Overview of Newborn Screening , 2010, Journal of developmental and behavioral pediatrics : JDBP.

[9]  André M Deelder,et al.  Oligosaccharide analysis by graphitized carbon liquid chromatography–mass spectrometry , 2009, Analytical and bioanalytical chemistry.

[10]  C. Lebrilla,et al.  Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. , 2011, The Analyst.

[11]  R. Contreras,et al.  N‐glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus , 2007, Hepatology.

[12]  N. Packer,et al.  A general approach to desalting oligosaccharides released from glycoproteins , 1998, Glycoconjugate Journal.

[13]  I. Rudan,et al.  Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. , 2010, Glycobiology.

[14]  I. Rudan,et al.  Variability, heritability and environmental determinants of human plasma N-glycome. , 2009, Journal of proteome research.

[15]  O. Salas-Solano,et al.  On-line CE-LIF-MS technology for the direct characterization of N-linked glycans from therapeutic antibodies. , 2008, Analytical chemistry.

[16]  Joris Delanghe,et al.  GlycoFibroTest Is a Highly Performant Liver Fibrosis Biomarker Derived from DNA Sequencer-based Serum Protein Glycomics*S , 2009, Molecular & Cellular Proteomics.

[17]  Erdmann Rapp,et al.  Optimized workflow for preparation of APTS-labeled N-glycans allowing high-throughput analysis of human plasma glycomes using 48-channel multiplexed CGE-LIF. , 2010, Journal of proteome research.

[18]  Yehia Mechref,et al.  Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. , 2008, Clinical chemistry.

[19]  Kit S. Lam,et al.  A Serum Glycomics Approach to Breast Cancer Biomarkers*S , 2007, Molecular & Cellular Proteomics.

[20]  Sharon Williams,et al.  What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research , 2007, Demography.

[21]  B. Keevil The analysis of dried blood spot samples using liquid chromatography tandem mass spectrometry. , 2011, Clinical biochemistry.

[22]  R. Contreras,et al.  N-glycomic changes in serum proteins during human aging. , 2007, Rejuvenation research.

[23]  Pauline M Rudd,et al.  Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. , 2007, Glycobiology.

[24]  G. V. Van Berkel,et al.  Fully automated liquid extraction-based surface sampling and ionization using a chip-based robotic nanoelectrospray platform. , 2010, Journal of mass spectrometry : JMS.

[25]  Y. Mechref,et al.  Alterations in the serum glycome due to metastatic prostate cancer. , 2007, Journal of proteome research.

[26]  Anthony B. Costa,et al.  New ionization methods and miniature mass spectrometers for biomedicine: DESI imaging for cancer diagnostics and paper spray ionization for therapeutic drug monitoring. , 2011, Faraday discussions.

[27]  Jin-Ming Lin,et al.  Development, characterization, and application of paper spray ionization. , 2010, Analytical chemistry.

[28]  L. R. Ruhaak,et al.  Glycan labeling strategies and their use in identification and quantification , 2010, Analytical and bioanalytical chemistry.

[29]  K. Killeen,et al.  Profile of native N‐linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time‐of‐flight mass spectrometry , 2009, Proteomics.

[30]  Kit S Lam,et al.  Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. , 2006, Journal of proteome research.

[31]  R. Contreras,et al.  Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics , 2004, Nature Network Boston.

[32]  L. Stolk,et al.  Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls , 2009, Therapeutic drug monitoring.

[33]  Yue Fan,et al.  Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. , 2011, Glycobiology.

[34]  Pauline M Rudd,et al.  Novel glycan biomarkers for the detection of lung cancer. , 2011, Journal of proteome research.

[35]  Kiyoko F. Aoki-Kinoshita,et al.  Frontiers in glycomics: Bioinformatics and biomarkers in disease An NIH White Paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11–13, 2006) , 2008, Proteomics.

[36]  Zheng Ouyang,et al.  Paper spray for direct analysis of complex mixtures using mass spectrometry. , 2010, Angewandte Chemie.